Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Artifoni M, Rothschild PR, Brezin A, et al. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:108–16.
Ball J. Rheumatoid arthritis and polyarteritis nodosa. Ann Rheum Dis. 1954;13:277–90.
Bartels CM, Bridges AJ. Rheumatoid vasculitis: vanishing menace or target for new treatments? Curr Rheumatol Rep. 2010;12:414–9.
Boers M, Croonen AM, Dijkmans BAC, et al. Renal findings in rheumatoid arthritis: clinical aspects of 132 necropsies. Ann Rheum Dis. 1987;46:658–63.
Bywaters EGL. A variant of rheumatoid arthritis characterized by recurrent digital pad nodules and palmar fasciitis, closely resembling palindromic rheumatism. Ann Rheum Dis. 1949;8:1–30.
Bywaters EGL. Peripheral vascular obstruction in rheumatoid arthritis and its relationship to other vascular lesions. Ann Rheum Dis. 1957;16:84–103.
Caimmi C, Crowson CS, Smith WM, et al. Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era. J Rheumatol. 2018;45:595–603.
Chen KR, Toyohara A, Suzuki A, et al. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol. 2002;147:905–13.
Coffey CM, Richter MD, Crowson CS, Koster MJ, Warrington KJ, Ytterberg SR, et al. Rituximab therapy for systemic rheumatoid vasculitis: indications, outcomes, and adverse events. J Rheumatol. 2020;47(4):518–23.
Conn DL, Schroeter AL, McDuffie FC. Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum. 1972;15:135.
Cruikschank B. The arteritis of rheumatoid arthritis. Ann Rheum Dis. 1954;13:136–45.
Epstein WV, Engleman EP. The relation of the rheumatoid factor content of serum to clinical neurovascular manifestations of rheumatoid arthritis. Arthritis Rheum. 1959;2:250–8.
Geirsson AJ, Sturfelt G, Truedsson L, et al. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis. 1987;46:727–33.
Harper L, Cockwell P, Howie AJ, et al. Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM. 1997;90:125–32.
Hurlimann D, Forster A, Noll G, et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106:2184.
Jebakumar AJ, Udayakumar PD, Crowson CS, et al. Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based study. J Rheumatol. 2014;41:437–43.
Johnson RL, Smyth CJ, Holt GW, et al. Steroid therapy and vascular lesions in rheumatoid arthritis. Arthritis Rheum. 1959;2:224–49.
Kaneko S, Yamashita H, Sugimori Y, Takahashi Y, Kaneko H, Kano T, et al. Rheumatoid arthritis-associated aortitis: a case report and literature review. Springerplus. 2014;3:509. https://doi.org/10.1186/2193-1801-3-509.
Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46:1489.
Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford). 2014;53(5):890–9. https://doi.org/10.1093/rheumatology/ket475.
Makol A, Matteson EL, Warrington KJ. Rheumatoid vasculitis: an update. Curr Opin Rheumatol. 2015;27(1):63–70. https://doi.org/10.1097/BOR.0000000000000126.
McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106:2380–6.
Mongan ES, Cass RM, Jacox RF, et al. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med. 1969;47:23–35.
Myasoedova E, Turesson C, Matteson EL. Extraarticular features of rheumatoid arthritis and systemic involvement. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 7th ed. Philadelphia: Elsevier/Mosby; 2018. p. 768–78.
Ntatsaki E, Mooney J, Scott DG, et al. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology (Oxford). 2014;53:145–52.
Oien RF, Hakansson A, Hansen BU. Leg ulcers in patients with rheumatoid arthritis--a prospective study of aetiology, wound healing and pain reduction after pinch grafting. Rheumatology (Oxford). 2001;40:816–20.
Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore). 2005;84:115.
Park YB, Ahn CW, Choi HK, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum. 2002;46:1714.
Price-Forbes AN, Watts RA, Lane SE et al. Do we need to treat isolated nailfold vasculitis (NFV) in rheumatoid arthritis (RA) more aggressively? Abstract 848, American College of Rheumatology annual scientific meeting, Oct 2002.
Puechal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum. 1995;38:1618–29.
Puechal X, Miceli-Richard C, Mejjad O, et al. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis. 2008;67:880–4.
Said G, Lacroix C. Primary and secondary vasculitis neuropathy. J Neurol. 2005;252:633–41.
Schmid FR, Cooper NS, Ziff M, et al. Arteritis in rheumatoid arthritis. Am J Med. 1961;30:56–83.
Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984;76(3):377–84.
Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore). 1981;60:288.
Shanmugam VK, DeMaria DM, Attinger CE. Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression. Clin Rheumatol. 2011;30:849–53.
Sokoloff L. The heart in rheumatoid arthritis. Am Heart J. 1953;45:635.
Squirrell DM, Winfield J, Amos RS. Peripheral ulcerative keratitis “corneal melt” and rheumatoid arthritis: a case series. Rheumatology. 1999;38(12):1245–8.
Turesson C, Matteson EL. Management of extraarticular disease manifestations in rheumatoid arthritis. Curr Opin Rheum. 2004;16:206–11.
Turesson C, Matteson EL. Extraarticular features of rheumatoid arthritis and systemic involvement. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 4th ed. Philadelphia: Mosby; 2008. p. 773–83.
Turesson C, O’Fallon WM, Crowson C, et al. Extraarticular disease manifestations in rheumatoid arthritis: incidence, trends, and risk factors over 46 years. Annals Rheumatic Dis. 2003;62:722–7.
Turesson C, McClelland R, Christianson TJ, Matteson EL. No decrease over time in the incidence of vasculitis or other extra-articular manifestations in rheumatoid arthritis (abstract). Arthritis Rheum. 2004;50:S380.
Turesson C, Schaid DJ, Weyand CM, et al. The impact of HLA-DRB1 genes on extraarticular disease manifestations in rheumatoid arthritis. Arthritis Res Ther. 2005;7:R1386–93.
Turesson C, Schaid DJ, Weyand CM, Jacobsson LT, Goronzy JJ, Petersson IF, et al. Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(9):2776–83.
Van Albada-Kuipers GA, Bruijn JA, Westedt ML, et al. Coronary arteritis complicating rheumatoid arthritis. Ann Rheum Dis. 1986;45:963.
Vollertsen RS, Conn DL, Ballard DJ, et al. Rheumatoid vasculitis: survival and associated risk factors. Medicine. 1986;65(6):365–75.
Voskuyl AE, Zwinderman AH, Wested ML, et al. The mortality of rheumatoid vasculitis compared with rheumatoid arthritis. Arthritis Rheum. 1996;39:266–71.
Wallberg-Jonsson S, Cvetkovic JT, Sundqvist KG, et al. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol. 2002;29:875.
Watts RA, Carruthers DM, Scott DG. Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis. 1995;54:927.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Makol, A., Kermani, T., Warrington, K., Stone, J.H., Matteson, E.L. (2023). Rheumatoid Vasculitis. In: Stone, J.H. (eds) A Clinician's Pearls & Myths in Rheumatology. Springer, Cham. https://doi.org/10.1007/978-3-031-23488-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-23488-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-23487-3
Online ISBN: 978-3-031-23488-0
eBook Packages: MedicineMedicine (R0)